1. Background {#sec1}
=============

Neurofibromatosis type 1 (NF1) affects approximately 1/3,000 individuals worldwide \[[@B1]\]. Diagnostic criteria are varied and include *café-au-lait* spots, neurofibromas, freckling of the axillary or inguinal regions, optic glioma, Lisch nodules, distinctive osseous lesions (such as sphenoid dysplasia or thinning of long bone cortex), as well as having a first-degree relative evidencing NF1 symptoms as detailed above \[[@B2]\].

Although NF1 is an autosomal dominant condition (familiar type), de novo mutations account for up to 50% of the cases (sporadic type). *NF1* is completely penetrant, nonetheless it exhibits variable clinical expressivity, even between family members with the same *NF1* mutation \[[@B3]\]. Most *NF1* mutations result in reduced intracellular levels of the protein neurofibromin, leading to excessive cell proliferation, including development of neurofibromas and tumours and diminished cognitive capacity \[[@B4]\].

In clinical practice, cognitive and behavioural problems associated with NF1 and their impact on academic performance is a common source of distress and the reason behind seeking help in child psychiatry. Indeed, between 30% and 70% of individuals with NF1 have learning disabilities concerning speech, reading, writing, spelling and mathematics. These problems represent the most significant cause of lifetime morbidity associated with the disease \[[@B5], [@B6]\]. Even though some phenotypic patterns have been suggested in the past, a more in-depth analysis reinforces the need to tailor the diagnosis and the treatment of these patients.

The global cognitive functioning of NF1 patients is usually preserved, although somewhat lower when compared to unaffected siblings or peer groups \[[@B7]\]. Intellectual disability, defined clinically as an intelligence quotient (IQ) lower than 70 in cognitive evaluations, is estimated to be around 4--8% in NF1 patients vs. 2-3% in the general population \[[@B8], [@B9]\]. However, the exclusion of patients with central nervous system (CNS) pathology from cohort studies of NF1 prevalence reduces the number of patients with clinically moderate to severe NF1 \[[@B8]\] and may underestimate the prevalence of intellectual disability amongst this population.

For many years the Child and Adolescent Psychiatry Department of Pitié-Salpêtrière has been treating paediatric patients who present neuropsychiatric symptoms of rare diseases \[[@B10]--[@B12]\] as examples. As a specialised team, the department receives complex patients which present significant management issues. NF1 patients are referred to this department. Here we describe patients with NF1 received in our Departement and highlight the benefits of a multidisciplinary assessment.

2. Methods {#sec2}
==========

2.1. Patients {#sec2.1}
-------------

Prospective data were gathered from NF1 patients (NIH, 1988) aged 7--15 years, referred by the Neurofibromatosis Referral Centre at Trousseau Paediatric Hospital for evaluation at the Department of Child and Adolescent Psychiatry at University Hospital La Pitié-Salpêtrière. The data spans from 2009 until 2016. The procedures regarding the assessments and follow-ups at the Referral Centre are described elsewhere \[[@B13]\]. Referrals were made due to additional difficulties either in management or diagnosis of patients and represented only a small part of the cohort (11/224---approximately 5%). No exclusion criteria were applied as we wanted to describe all complex aspects of this clinical sub sample.

2.2. Procedures and Instruments {#sec2.2}
-------------------------------

Patients were assessed in medical consultations and further comprehensive evaluations. For the selected cases, we extracted from the prospective database: sociodemographic data (age, sex, academic level); all relevant information from the semi-structured medical interview to evaluate the patient\'s personality and family history of psychiatric and medical disorders, including NF1 clinical features, complications and follow-ups; and all relevant biological (e.g. genetic testing), physiological (e.g. electro-encephalography) and imaging (e.g. magnetic resonance imaging) information. In addition, we performed (1) a psychiatric assessment; (2) a tailored neuropsychological evaluation (e.g. executive function, attention, memory, neurovisual) based on clinical demands and history; (3) a broad speech evaluation, if there were language (oral and/or written) concerns or learning difficulties; (4) a global and fine motor skills evaluation, if there were concerns regarding motor abilities and/or learning difficulties (such as difficulties to write), and (5) autism specific evaluations, if clinically relevant. The list of testing is given in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}.

Evaluations were performed because they had clinical relevance. They were adapted to the needs and characteristics of each patient. Medical files containing clinical data were thoroughly explored (AM, AJ, MP) and relevant data were included (AM, AJ, AT, MP). Psychiatric diagnoses were made according to DSM-5 criteria. Finally, the scores obtained in neuropsychological, speech and fine motor skills assessments were converted into standard deviations in order to have unique common statistics and to ease presentation.

3. Results {#sec3}
==========

Eleven patients were included. All, except one, were boys with a mean age of 10.6 (range 7--15) years. Five patients had a first degree relative with NF1 (father, mother or sibling). Two patients lived in foster care and five with one parent (due to divorce). One had Legius syndrome, a genetic condition associated with *sprouty related EVH1 domain containing 1 (SPREAD1)*gene mutation, which phenotype overlaps that of NF1 \[[@B14]\]. For clarity, we present the patients in two separate tables. [Table 1](#tab1){ref-type="table"} summarises the clinical profile of four NF1 patients with an intellectual deficiency and [Table 2](#tab2){ref-type="table"} presents the profile of patients with subnormal IQ.

3.1. Reasons for Referral {#sec3.1}
-------------------------

Patients came with multiple and diverse complaints. Reasons for referral included learning difficulties (due to the consequences of instrumental difficulties, suspicion of attention deficit hyperactivity disorder (ADHD) or intellectual disability; *N* = 7), or emotional problems or suspicion of emergent psychopathology (*N* = 6). A few (*N* = 4) were referred because of autism spectrum disorder (ASD) (doubts regarding diagnosis or difficulties in clinical management).

3.2. NF1 Clinical Characteristics and Intellectual Impairment {#sec3.2}
-------------------------------------------------------------

Clinical complications of NF1 (skeletal, vascular, malignancy, epilepsy, precocious puberty, the presence of unidentified bright objects (UBOs) in CNS) were present in patients who also had a certain degree of intellectual disability ([Table 1](#tab1){ref-type="table"}), sometimes accompanied by autistic features (patients 1, 2, 4; [Table 1](#tab1){ref-type="table"}). Only, one patient with NF1 complications did not present with an intellectual disability but had a borderline IQ (patient 8; [Table 2](#tab2){ref-type="table"}). In four patients, UBOs were present mainly in the cerebellum and the basal ganglia (patients 1, 2, 4 and 8). NF1 complications motivated frequent medical appointments and hospitalisations, an additional burden for patients and their families. For all the other patients ([Table 2](#tab2){ref-type="table"}) only mild NF1 features, such as café-au-laits spots, intertriginous freckling, few neurofibromas and/or Lisch nodules, were present. These patients all had subnormal IQ.

3.3. NF1 and Learning Disabilities {#sec3.3}
----------------------------------

All patients had learning disabilities that appeared as a primary or secondary cause of referral. For the patients who had subnormal IQ scores ([Table 2](#tab2){ref-type="table"}), it was common to find discrepancies in IQ sub-scales. Within each subscale, scores could vary widely (data not shown). Even if the patients received an*average/mean* IQ, their global intellectual efficiency was weaker when compared to the general population.

Specific learning disabilities were also common. They included specific language developmental delays (patients 5, 6, 9, 11; [Table 2](#tab2){ref-type="table"}), graphomotor delays (patients 5, 6, 7, 8; [Table 2](#tab2){ref-type="table"}) and developmental coordination disorders (dyspraxia) (patients 8, 9; [Table 2](#tab2){ref-type="table"}). Some patients also had comorbid ADHD (patients 5, 6, 8; [Table 2](#tab2){ref-type="table"}). The extensive developmental evaluation was crucial to disentangle diagnosis and also to guide further therapeutic propositions. Such specific propositions included school adaptations (such as having more time to finish evaluations, the use of computer to write), speech and reading therapies once or twice per week, and motor skills remediation once per week, that lead to improvement (nonpharmacological treatment; [Table 2](#tab2){ref-type="table"}).

Patients with intellectual disabilities ([Table 1](#tab1){ref-type="table"}) arguably presented learning difficulties. Standard tests for cognitive evaluation (such as the Wechsler intelligence scale for children, WISC \[[@B29]\]) were difficult to perform in such patients. In these cases, clinical evaluation and developmental scales were helpful (Brunet Lezine \[[@B18]\]), Terman Merrill \[[@B25]\]), as well as some psychosocial scales (Psychoeducational Profile (PEP) \[[@B23]\], Vineland \[[@B28]\]) that estimate performance in more ecologic day to day activities. In this context, specific evaluations of language, motor, and attentional domains are equally important to guide tailored intervention strategies. Intervention strategies were generally more global in the context of schooling for disabled children.

3.4. NF1 and Attentional Issues {#sec3.4}
-------------------------------

Four of our patients had an ADHD diagnosis, obtained after clinical assessment and a specific neuropsychological evaluation (Test of Everyday Attention for Children, TEA-Ch \[[@B24]\]). A fifth patient (patient 4; [Table 1](#tab1){ref-type="table"}) diagnosed with ADHD was evaluated through clinical observation and functional scales (Conners \[[@B20]\]), because the neuropsychological evaluation was difficult to perform given the intellectual deficit. In all cases, an ADHD diagnosis was made along with other comorbidities and was never isolated. Four patients were treated with methylphenidate and one was given specific cognitive training addressing attention. Three patients receiving methylphenidate improved and one stopped the treatment due to side effects.

3.5. NF1, Emotional Problems and Emergent Psychopathology {#sec3.5}
---------------------------------------------------------

The most frequent diagnosis was anxiety disorder and/or NF1 related stress (patients 1, 4, 7, 10, 11). Two visited for the evaluation and treatment of mood disturbances (patients 8, 11; [Table 2](#tab2){ref-type="table"}). Finally, another patient visited for psychiatric evaluation in the context of sexual assault (patient 3; [Table 1](#tab1){ref-type="table"}). Medication along with nonpharmacological treatments such as different types of psychotherapy were proposed and appeared to be helpful.

3.6. NF1 and Autistic Spectrum Symptomatology {#sec3.6}
---------------------------------------------

Four patients presented clear autistic features after clinically comprehensive/developmental assessment and additional assessment tools (patients 1, 2, 4; [Table 1](#tab1){ref-type="table"} and patient 9, [Table 2](#tab2){ref-type="table"}). Three patients with autistic features had concurrent intellectual disability ([Table 1](#tab1){ref-type="table"}). A fifth patient with an ongoing history of social difficulties had a pragmatic communication disorder (patient 5; [Table 2](#tab2){ref-type="table"}). Complementary psychological tests were helpful for the diagnosis (CARS \[[@B19]\], ADI \[[@B15]\], ADOS \[[@B16]\]). Treatment strategies addressed co-morbidities as well as core features of autism (e.g., social strategies in group) in outpatient settings or in the context of specific schooling models.

4. Discussion {#sec4}
=============

This case series reflects the variety of problems and the complexity of severe NF1 paediatric patients. The gender bias reflected in our sample may result from the overrepresentation of boys in child and adolescent psychiatry consultations and therefore will not necessarily reflect the epidemiology of NF1 \[[@B30]\]. Also, the morbimortality of the disease, is mild to moderate in most cases. Nonetheless, clinical complications of NF1 can present a serious burden. This was the case for most of the patients reported here, who were referred to a special psychiatric clinic for rare diseases. The large heterogeneous phenotypic expression of NF1 is likely to be a consequence of the stochastics chain of events associated with NF1. At a molecular level, the reduced intracellular levels of neurofibromin found in NF1 patients induce impairments in learning and memory through imprecise, i.e. abnormally high or low RAS modulation and consequential gamma-aminobutyric acid (GABA)-mediated excessive inhibition in the hippocampus \[[@B4], [@B31]\]. Also, patients with NF1 may show subcortical unidentified bright objects (UBOs) as we found in four of our patients. In all but one, UBOs were present in patients with intellectual disability and a multitude of somatic complications of the disease. UBOs are present in approximately 60--70% \[[@B32], [@B33]\] of the children with NF1 but tend to disappear with age. Histopathologic studies have shown that UBOs correspond to areas of myelin vacuolization with increased water content \[[@B34]\] and therefore, could reflect disordered myelination \[[@B35]\]. The presence of UBOs has been associated with lower intellectual ability \[[@B36], [@B37]\] and also visuospatial impairments when UBOs were located in the cerebellum \[[@B38]\]. The latter seems to be the case for patients 1 and 2 ([Table 1](#tab1){ref-type="table"}) and patient 8 ([Table 2](#tab2){ref-type="table"}) in our case series.

4.1. NF1 Cognitive Impairment and Learning Disabilities {#sec4.1}
-------------------------------------------------------

In this case series, the patients presented either a degree of intellectual disability ([Table 1](#tab1){ref-type="table"}) or an average but heterogeneous cognitive profile with significant functional impairments ([Table 2](#tab2){ref-type="table"}). Many studies have now made clear how intelligence is only mildly affected in the vast majority of NF1 patients. However, specific impairments in cognition are very common (up to 80% of children in NF1 clinics \[[@B8]\]) and have a negative impact in the quality of life. Some specific deficits have been reported to NF1: visual-spatial deficits \[[@B39]\], speech and language deficits, motor skill deficits \[[@B40]\], social skill deficits \[[@B5], [@B41]\] and attentional deficits \[[@B8], [@B42]\]. All may lead to learning disabilities and further emotional suffering. The presence of visual-spatial and attentional deficits has been robustly replicated \[[@B7], [@B43]\]. However, research has revealed contradictory results regarding motor skills and language performance in patients with NF1 \[[@B7]\]. Moderate to severe intellectual disability and severe clinical cases seemed to be the focus of interest of early works in neurofibromatosis \[[@B44]\] but severe cases of NF1 have received little attention recently.

4.2. NF1 and ADHD {#sec4.2}
-----------------

In all our NF1-ADHD patients, the ADHD diagnosis was made along with other comorbidities and was never isolated. Patients with NF1 present more symptoms and are more often diagnosed with ADHD than the general population. Prevalence estimates range from 30% to 50% \[[@B45], [@B46]\], which are higher than those expected in the general population, i.e. about 5% in children and 2.5% in adults \[[@B47], [@B48]\].

Clinical and cognitive profiles of both ADHD patients with and without NF1 are heterogeneous. Individuals are affected in different domains of attention, impulsivity, hyperactivity and executive functioning, and to different degrees \[[@B46], [@B49]\]. Visual attention seems consistently impaired in NF1 patients \[[@B50], [@B51]\] and would lead to instability in focusing attention and lower resistance to interference in controlled tasks but also to inattentive and impulsive behaviour in natural environments.

Importantly, ADHD-NF1 patients seem responsive to methylphenidate \[[@B42], [@B46]\]. This improvement has been also reported for children with IQs lower than 80 \[[@B46]\]. In our case series, four of the patients diagnosed with ADHD were treated with methylphenidate, three showing a great improvement and one dropping out of treatment due to side effects.

The high frequency of ADHD in children with NF1, as well as the demonstrated significant comorbidity of ADHD with literacy learning disabilities \[[@B8]\] and social skills problems \[[@B52]\] indicates the need for thorough screening of ADHD symptomatology in all children with NF1 \[[@B45]\]. Besides, the impact of attention deficits and behaviour problems in children with NF1 often leads to lower social acceptance and lack of self-confidence/esteem. When emotional problems are secondary to ADHD, effective treatment of ADHD can improve them both \[[@B46]\].

4.3. NF1 and Autistic Spectrum Symptomatology {#sec4.3}
---------------------------------------------

After some early work evoking associations between autism and NF1 \[[@B53]\] there is a re-enacted concern regarding ASD and NF1. Since Huijbregts and de Sonneville \[[@B54]\] showed that NF1 impairments in cognitive control (i.e. a combination of processing speed, working memory, inhibitory control, and emotional processing functions) is associated with the presence of autistic traits, several studies have explored the prevalence of ASD symptoms in NF1 populations.

Studies focusing on social impairments as a continuous variable within the social responsiveness scale (SRS) \[[@B55]--[@B58]\] showed that NF1 patients present more social impairments than the general population (up to 40% in some samples \[[@B56]\]). Whether or not this is enough to state that ASD is increased in NF1 patients is another question. First, ASD screening tools are not meant to provide a diagnosis of ASD, but rather identify children who should be further evaluated. Second, NF1 patients with high SRS scores show mild to moderate ASD symptomatology (e.g. latter diagnosis during school years; no stereotyped behaviours) \[[@B57]\]. We believe that research should explore further the meaning of ASD symptomatology in NF1. Given the rarity of stereotyped behaviours in NF1, perhaps the DSM-5 diagnosis of social communication disorder will be more appropriate in some cases? Also, is it legitimate to use SRS score as a continuous variable? Indeed, when re-analysing the largest cohort of NF1 so far that reported SRS scores \[[@B59]\] we found that the best model to predict data distribution using admixture analysis was a bimodal distribution ([Figure 1](#fig1){ref-type="fig"}), with a large group of patients with a mean SRS score equal to 55 (red curve), and a smaller group of patients with a higher mean SRS score equal to 70 (green curve). This means that considering SRS as a continuous variable showing a normal distribution may be inappropriate. This also means that NF1 phenotype heterogeneity might be better understood separating subgroups of patients as it has been shown in other genetically complex neurodevelopmental disorders.

However, we do believe that rare typical cases of ASD can also be encountered in NF1. Three patients in this case series presented an unequivocal profile of ASD comorbid with intellectual disability. Several authors postulated that autism associated with neurogenetic syndromes can be classified as "complex autism" or "syndromic autism" \[[@B60]--[@B62]\]. Complex autism is characterised by lower IQ, higher rates of comorbidities both psychiatric and somatic, and higher rates of epilepsy \[[@B63], [@B64]\]. For these severe cases, this classification may be useful to better explore their clinical profile and tailor treatment to the child\'s needs \[[@B65]\].

4.4. NF1 and Emotional Problems {#sec4.4}
-------------------------------

NF1 has also significant social and psychological consequences on individuals and their families \[[@B66], [@B67]\]. Most patients of this case series were referred with emotional problems. While some (*n* = 7) had behavioural difficulties (sometimes secondary to ADHD or to learning disabilities), others expressed internalising symptoms such as anxiety or depression. These conditions can often be found in NF1 \[[@B67]\]. The emotional impact of cosmetic deformities, the fear of malignancy, and the medical complications, such as the management of hypertension or the need for surgical interventions should be carefully evaluated and not be neglected. Learning difficulties can also generate feelings of low self-esteem and inefficiency that can last in time. In addition, the impact of attention deficits and behaviour problems in children with NF1 often leads to lower social acceptance and lack of self-confidence. As mentioned previously, when emotional problems are secondary to ADHD, effective treatment of ADHD can improve them both \[[@B46]\]. Besides, parents of NF1 children experience greater stress than other parents \[[@B68]\], sometimes associated with feelings of guilt regarding the genetic transmission of NF1. The parents should also receive proper care.

4.5. Treatment Modalities and Outcome {#sec4.5}
-------------------------------------

Strategies that decrease either RAS activity or GABA-mediated inhibition have been suggested to specifically treat learning and emotional deficits associated with NF1. Pharmacologically targeting this pathway with an HMG-CoA reductase inhibitor (an anti-RAS agent), such as lovastatin \[[@B69]\] evidenced some encouraging results in animal models. However, to date, clinical trials with NF1 patients have shown modest results \[[@B70]--[@B72]\]. Therefore, current treatment options remain symptomatic. The heterogeneity of NF1 phenotypical manifestations needs to be considered when developing assessment and remediation approaches for children with NF1. The outcome is therefore variable, different for each patient.

5. Conclusions {#sec5}
==============

In severe cases of NF1 with important psychiatric morbidity, it can sometimes be difficult to disentangle specific domains of impairment, as cognition as a whole is complex. In day-to-day activities, more than one cognitive domain is needed to perform adequately, making the task of disentanglement even more challenging. This is why a multidimensional and longitudinal clinical evaluation is warranted when assessing patients.

Phenotype-genotype correlations tend to subscribe the idea that behavioural manifestations present themselves with continuous variation. This type of pattern was proposed for NF1 autistic symptoms \[[@B59]\]. However, we believe that more complex phenotype/genotype association occurs in NF1 for psychiatric comorbidity including ASD symptomatology. Similarly to other genetic conditions such as juvenile myotonic dystrophy \[[@B73]\], or tuberous sclerosis \[[@B74]\], bimodal phenotypic patterns of intelligence/cognitive performance seem to adapt better to the distribution of IQ scores in these populations. In terms of clinical implications, the heterogeneity of NF1 phenotypical manifestations needs to be considered when developing assessment and remediation approaches for children with NF1.
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###### 

Clinical profile of NF1 patients with an intellectual deficiency.

                                                                                                          Patient 1                                                                                                  Patient 2                                                            Patient 3                                                 Patient 4
  ------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------------------------------------
  Sex, age                                                                                                Male, 12 years                                                                                             Male, 13 years                                                       Male, 15 years                                            Female, 8 years
                                                                                                                                                                                                                                                                                                                                                    
  Main reasons for referral                                                                               Increasing puberty-onset aggressiveness                                                                    ASD assessment                                                       Psychiatric assessment in the context of sexual assault   Suspicion of ADHD
  Suspicion of ADHD                                                                                       Suspicion of ADHD                                                                                          Outpatient unit                                                      Social problems (foster care)                             
  Inpatient unit                                                                                          Outpatient unit                                                                                            Outpatient unit                                                                                                                
                                                                                                                                                                                                                                                                                                                                                    
  NF1 diagnosis                                                                                           Familial NF1 (including intellectual disability)                                                           Sporadic NF1                                                         Familial NF1                                              Familial NF1
  Additional genetic research was negative: karyotype, x fragile                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                    
  NF1 complications                                                                                       Dystrophic thoracic scoliosis                                                                              Sphenoid bone dysplasia                                              Bilateral optic pathway tumor, remission                  Optic pathway tumor, remission
  Sphenoid bone dysplasia                                                                                 Orbicular-facial plexiform neurofibroma (surgically removed)                                               Precocious puberty                                                                                                             
  Labile renovascular hypertension                                                                        UBOs**:** basal ganglia, cerebellum                                                                        Epilepsy                                                                                                                       
  Intermittent claudication                                                                               UBOs: left pallidum, white matter                                                                                                                                                                                                         
  Several complicated surgical interventions/hospitalisations                                                                                                                                                                                                                                                                                       
  Absence of pheocromocytoma or precocious puberty                                                                                                                                                                                                                                                                                                  
  UBOs: bilateral temporal; right lentiform nucleus; cerebellum/protuberance                                                                                                                                                                                                                                                                        
  Blindness                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                    
  Developmental delay (early history)                                                                     Vineland (age 4): developmental delays ranging from 7--39 months                                           Hypoxia at birth                                                     ?? (family poorly informative)                            Prematurity
  (Repeated gastroenteritis during childhood)                                                             (Repeated gastroenteritis during childhood)                                                                PEP-R (age 3): Average developmental delay 11--13 months                                                                       
                                                                                                                                                                                                                                                                                                                                                    
  Cognitive assessment                                                                                    TERMAN--MERRILL                                                                                            PEP-3: mild intellectual disability                                  Assessment not available                                  BRUNET-LEZINE (age 3): Developmental delays ranging from 8--14 months
  Moderate intellectual disability                                                                        Divided attention TEA-Ch: −2.6SD                                                                                                                                                                                                          
  Unimodal attention TEA-Ch −2.6SD                                                                                                                                                                                                                                                                                                                  
  Language EXALANG: delays in all domains (oral/written) (average: −1.7SD)                                                                                                                                                                                                                                                                          
  Flexibility NEPSY-II: −1.4SD                                                                                                                                                                                                                                                                                                                      
  Working memory NEPSY-II: −1.4SD                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                    
  ASD assessment                                                                                          CARS (age 4) = 30.5 (mild autism)                                                                          Clinical evaluation: repetitive behaviors and perseverant thoughts   No clinical suspicion                                     ADOS
  ADI-R: stereotypies = 9 (threshold 3)                                                                   Deficits in social cognition/pragmatics: −1.3SD ^EMOTION\ COMPREHENSION\ TEST^                             Communication domain = 6 (threshold 4)                                                                                         
  Communication domain = 14 (threshold 8)                                                                 Social interaction = 14 (threshold 7)                                                                                                                                                                                                     
  Other: anxiety                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                    
  Psychiatric diagnosis                                                                                   Moderate intellectual disability                                                                           Mild intellectual disability                                         Mild intellectual disability                              Moderate intellectual disability
  Autism                                                                                                  Autism                                                                                                     Autism                                                                                                                         
  Dyspraxia                                                                                               Dyspraxia                                                                                                  Dyspraxia                                                                                                                      
  NF1 related stress (comorbidities)                                                                      ADHD-hyperkinetic type                                                                                     NF1 related stress (comorbidities)                                                                                             
  No criteria for ADHD                                                                                    ADHD-hyperkinetic type ^CONNERS;\ clinical\ assessment^                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                    
  Medication                                                                                              Aripiprazole                                                                                               Methylphenidate                                                      None                                                      Levetiracetam
  Melatonin                                                                                               Melatonin                                                                                                  Enantone                                                                                                                       
  Labetalol                                                                                               Methylphenidate                                                                                                                                                                                                                           
  Clonidine                                                                                               Risperidone                                                                                                                                                                                                                               
  Melatonin                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                    
  Nonpharmacological treatment                                                                            Full time school for disabled adolescents, including remediation to improve attention, speech, motricity   Full time school for autistic adolescents                            Full time school for disabled adolescents                 Full time school for disabled children, including remediation to improve attention, speech, motricity.
  Regular follow-up                                                                                       Adapted school activities, including remediation to improve attention                                      Regular psychiatric follow up                                        Foster family                                             
  Regular multidisciplinary discussion                                                                    Speech remediation in the past                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                    
  Outcome                                                                                                 Clinical improvement                                                                                       Stable                                                               Improvement                                               Improvement (less than expected due to social difficulties)
  Balancing day-to-day life with the ongoing co-morbidities of NF1 is a challenge to him and his family   Balancing day-to-day life with the ongoing co-morbidities of NF1 is a challenge to her                                                                                                                                                    

ADHD, attention deficit hyperactivity disorder; ADI-R, autism diagnostic interview-Revised \[[@B15]\]; ADOS, autism diagnostic observation schedule \[[@B16]\]; ASD, autism spectrum disorder; BRUNET-LEZINE, First childhood psychomotor developmental schedule \[[@B18]\]; CARS, The childhood autistic rating scale \[[@B19]\]; CONNERS, Conner\'s continuous performance test \[[@B20]\]; EMOTION COMPREHENSION TEST, Test of emotion comprehension \[[@B27]\]; EXALANG, language evaluation for children 8--11 years \[[@B21]\]; NEPSY-II, Neuropsychological test for children \[[@B22]\]; NF1, Neurofibromatosis type 1; PEP, Psychoeducational profile: Revised (PEP-R) and third edition (PEP-3) \[[@B23]\]; TEA-Ch, test of everyday attention for children \[[@B24]\]; TERMAN-MERRILL, Stanford-Binet intelligence scale \[[@B25]\]; UBOs, unidentified bright objects; VINELAND, adaptive behaviour scales \[[@B28]\].

###### 

Clinical profile of NF1 patients with subnormal IQ.

                                        Patient 5                                                     Patient 6                                                    Patient 7                                                                                             Patient 8                                                    Patient 9                                                      Patient 10                                                     Patient 11
  ------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------ ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------
  Sex, age                              Male, 10 years                                                Male, 8 years                                                Male, 8 years                                                                                         Male, 9 years                                                Male, 15 years                                                 Male, 7 years                                                  Male, 12 years
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Main reason for referral              Learning difficulties                                         Learning difficulties                                        Learning difficulties                                                                                 Intermittent explosive behaviour; ADHD                       Confirmation of ASD (ADOS-ADI-R)                               Suspicion of ADHD                                              Mood disorder
  Anxiety symptoms                      Behavioural difficulties                                      Hyperactivity sleep; family related issues                   NF1 complications: Precocious puberty; nondysplastic scoliosis; UBOs: cerebellum, *globus pallidus*   Emotional lability                                           NF1 related stress                                             Learning difficulties                                          
  Social difficulties                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Outpatient unit                       Outpatient unit                                               Outpatient unit                                              Outpatient unit                                                                                       Outpatient unit                                              Outpatient unit                                                Outpatient unit                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  NF1 diagnosis                         Familial NF1                                                  Familial NF1                                                 Sporadic NF1                                                                                          Sporadic NF1                                                 Sporadic NF1                                                   Sporadic NF1                                                   Legius SD
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Developmental delay                   Minor (graphic abilities)                                     No                                                           Minor (global motor)                                                                                  Walking unstable at 21 months                                ???                                                            No                                                             Not reported
  Repeated otitis                                                                                     Prematurity                                                  Speech delay (Repeated otitis)                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Cognitive assessment WISC-IV          Verbal: 92; performance: 121; working memory: 97; speed: 88   Verbal: 86; performance: 77; working memory: 73; speed: 71   Verbal: 92; performance: 94; working memory: 76; speed: 78                                            Verbal: 98; performance: 65; working memory: 82; speed: 83   Verbal: 86; performance: 73; working memory: 109; speed: 100   Verbal: 92; performance: 109; working memory: 91; speed: 103   Verbal: 94; performance: 90; working memory: 73; speed: 66
  Heterogeneous                         Heterogeneous                                                 Heterogeneous                                                Heterogeneous                                                                                         Heterogeneous                                                Heterogeneous                                                  Heterogeneous                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Attention and executive functions     Divided attention ^TEA-Ch^: −2SD                              Divided attention ^TEA-Ch^: −1.4SD                           Divided attention ^TEA-Ch^: Normal                                                                    Divided attention ^TEA-Ch^: −0.5SD                                                                                          Divided attention ^TEA-Ch^: +0.7SD                             
  Unimodal attention ^TEA-Ch^: Normal   Unimodal attention ^TEA-Ch^: −1.4SD                           Unimodal attention ^TEA-Ch^: Normal                                                                                                                                Unimodal attention ^TEA-Ch^: −0.7SD                          Unimodal attention: ^TEA-Ch^ +0.3SD                            Unimodal attention ^TEA-Ch^: −0.7SD                            
                                        Sustained attention ^TEA-Ch^: −1.7SD                                                                                                                                                                                                                                                                                                                                                                                        
                                        Attention control ^TEA-Ch^: -2.2SD                            Attention control ^TEA-Ch^: +0.7SD                                                                                                                                                                                                                                                                                                                            
                                        Inhibition ^TEA-Ch^: −2SD                                                                                                                                                                                                                                                                     Inhibition ^TEA-Ch^: +1SD                                                                                                     
  Flexibility ^NEPSY-II^: −0.1SD        Flexibility ^NEPSY-II^: −1.5SD                                Flexibility ^NEPSY-II^: −0.5SD                               Flexibility ^NEPSY-II^: −1.5SD                                                                        Flexibility ^NEPSY-II^: −1.4SD                               Flexibility ^NEPSY-II^: −0.1SD                                 Flexibility ^NEPSY-II^: −0.2SD                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Memory                                Short-term ^NEPSY-II^: −0.1SD                                 Short-term ^NEPSY-II^: −1.2SD                                Short-term: −1.6SD                                                                                                                                                 Short-term ^NEPSY-II^: −0.3SD                                  Short-term ^NEPSY-II^: −0.7SD                                  Short-term ^NEPSY-II^: −0.3SD
  Episodic^REY^: −0.3SD                 Episodic^REY^: +0.5SD                                                                                                                                                                                                                                                                         Episodic^REY^: +0.4SD                                          Episodic^REY^: −3SD                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Language assessment EXALANG           Oral receptive: -0.7SD                                        Oral receptive: −1.5SD                                       Oral expressive: +1.4SD                                                                               Normal                                                       Normal                                                         Normal                                                         Oral lexicon: −1.3SD
  Oral expressive: −0.5SD               Oral expressive: −2SD                                         Oral lexicon: −0.5SD                                                                                                                                                                                                                                                                                                                                          
  Oral lexicon: +0.7SD                  Oral lexicon: −1.2SD                                                                                                                                                                                                                                                                                                                                                                                                        
  Written receptive: −2.6SD             Written expressive: −1.7SD                                    Written receptive: +1.4S                                                                                                                                                                                                                                                                       Written expressive: −2.6                                       
  Written expressive: −2.9SD                                                                          Written expressive: −0.5SD                                                                                                                                                                                                                                                                                                                                    
  Spelling: −2.6SD                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Motricity                             Visuo-construction^REY^: +0.5SD                               Visuo-construction^REY^: Normal                              Visuo-construction^REY^: −0.7SD                                                                       Visuo-construction^REY^: −3SD                                Visuo-construction^REY^: −0.3SD                                Visuo-construction^REY^: +0.2SD                                Visuo-construction^REY^: −0.7SD
  Visuo-spatial ^NEPSY-II^: +0.5SD      Visuo-spatial ^NEPSY-II^: −0.6SD                              Visuo-spatial ^NEPSY-II^: −0.3SD                             Visuo-spatial ^NEPSY-II^: −0.1SD                                                                      Visuo-spatial ^NEPSY-II^: −0.8SD                             Visuo-spatial ^NEPSY-II^: +0.3SD                               Visuo-spatial ^NEPSY-II^: −0.8SD                               
  Graphomotor skill^BHK^: −2.3SD        Graphomotor skill^BHK^: −2SD                                  Graphomotor skill^BHK^: −2SD                                 Graphomotor skill^BHK^: −2SD                                                                          Graphomotor skill^BHK^: +1.4SD                               Graphomotor skill^BHK^: +0.4SD                                 Graphomotor skill ^BHK^: −0.3SD                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Socio-cognition/pragmatic             −0.7SD                                                        −0.3SD                                                                                                                                                                                                                          −2.2SD                                                         −1SD                                                           Normal
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Psychiatric Diagnosis                 ADHD-inattentive type                                         *Borderline* intelligence                                    Anxious disorder                                                                                      *Borderline* intelligence                                    ASD (Asperger)                                                 Anxiety disorder                                               Mood disorder
  Dyslexia                              ADHD-impulsive type                                           Motor (graphic) delay                                        ADHD, ODD                                                                                             Dysexecutive profile                                                                                                        Attachment disorder                                            
  Pragmatic communication disorder      Dysexecutive profile                                                                                                       Visual-Spatial Dyspraxia                                                                              Dyspraxia                                                                                                                   Written language difficulties                                  
                                        At risk for dyslexia                                                                                                       Dysgraphia                                                                                                                                                                                                                        NF1 related stress                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Medication                            Methylphenidate                                               Methylphenidate (not well tolerated)                         Melatonin                                                                                             Methylphenidate                                              Aripiprazole                                                   None                                                           Quetiapine
  Triptorelin Acetate                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Nonpharmacological treatment          Specific school adaptations                                   Specific school adaptations                                                                                                                                        Specific school adaptations                                  Specific school adaptations                                                                                                   
  Speech and reading therapy            Speech and reading therapy                                                                                                 Speech and reading therapy (past)                                                                     Language and motor remediation in the past                                                                                  Speech and reading therapy                                     
  Motor skills remediation              Motor skills remediation                                      Motor skills remediation                                     Motor skills remediation                                                                              Social strategies group                                                                                                                                                                    
                                                                                                      Psychotherapy                                                Psychodrama therapy                                                                                                                                                Psychotherapy                                                  Psychiatric follow-up                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Outcome                               Improvement                                                   Improvement                                                  Stable                                                                                                Improvement                                                  Stable                                                         Stable                                                         Stable

ADHD, attention deficit hyperactivity disorder; ADI-R, autism diagnostic interview-Revised \[[@B15]\]; ADOS, autism diagnostic observation schedule \[[@B16]\]; ASD, autism spectrum disorder; BHK, concise evaluation scale for children handwriting \[[@B17]\]; EMOTION COMPREHENSION TEST, Test of emotion comprehension \[[@B27]\]; EXALANG, language evaluation for children 8--11 years \[[@B21]\]; NEPSY-II, Neuropsychological test for children \[[@B22]\]; NF1, Neurofibromatosis type 1; ODD, oppositional defiant disorder; TEA-Ch, test of everyday attention for children \[[@B24]\]; REY, Rey\'s complex figure test \[[@B25]\]; UBOs, unidentified bright objects\]; WISC IV, the Wechsler intelligence scale for children \[[@B29]\].
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